457 related articles for article (PubMed ID: 35962694)
1. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
Dobrek Ł
Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
[TBL] [Abstract][Full Text] [Related]
2. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Dobrek Ł
Pol Merkur Lekarski; 2022 Oct; 50(299):323-327. PubMed ID: 36283018
[TBL] [Abstract][Full Text] [Related]
6. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
7. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
Hsu CN; Tain YL
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
Sumida K; Pierre JF; Yuzefpolskaya M; Colombo PC; Demmer RT; Kovesdy CP
Semin Nephrol; 2023 Mar; 43(2):151408. PubMed ID: 37619529
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
10. Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
Sumida K; Lau WL; Kovesdy CP; Kalantar-Zadeh K; Kalantar-Zadeh K
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):75-84. PubMed ID: 33148949
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut-Kidney Axis.
Huang HW; Chen MJ
J Agric Food Chem; 2024 Apr; 72(15):8347-8364. PubMed ID: 38571475
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and prebiotics modulation of uremic toxin generation.
Koppe L; Fouque D
Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
[TBL] [Abstract][Full Text] [Related]
14. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
15. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
16. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
[TBL] [Abstract][Full Text] [Related]
17. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
18. Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases.
Liu X; Wang X; Zhang P; Fang Y; Liu Y; Ding Y; Zhang W
Front Immunol; 2023; 14():1266792. PubMed ID: 38022571
[TBL] [Abstract][Full Text] [Related]
19. Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature.
Feng Z; Wang T; Dong S; Jiang H; Zhang J; Raza HK; Lei G
J Int Med Res; 2021 Oct; 49(10):3000605211053276. PubMed ID: 34704483
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
